AVEO Oncology
AVEO
#7488
Rank
C$0.74 B
Marketcap
C$21.38
Share price
0.00%
Change (1 day)
175.63%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -C$37.21 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are C$94.31 Million. In 2021 the company made an earning of -C$76.04 Million a decrease over its 2020 earnings that were of -C$50.73 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -C$37.21 Million-51.07%
2021 -C$76.04 Million49.9%
2020 -C$50.73 Million-479.04%
2019 C$13.38 M-276.17%
2018 -C$7.6 Million-91.79%
2017 -C$92.55 Million142.38%
2016 -C$38.19 Million78.51%
2015 -C$21.39 Million-71.55%
2014 -C$75.18 Million-50.72%
2013 -C$0.16 Billion-4.88%
2012 -C$0.17 Billion-426.29%
2011 C$49.15 M-159.85%
2010 -C$82.14 Million35.33%
2009 -C$60.7 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Eli Lilly
LLY
C$47.88 B-115,791.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$14.66 B-35,524.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$1.44 B-3,582.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
C$7.36 B-17,889.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$16.97 B-41,113.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-C$3.22 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA